Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials

Publication | Open Access

DOI Full Paper Access

166

Citations

References

2014

Year

Hans‐Joachim Schmoll, Chris Twelves, Weijing Sun, Michael J. O’Connell, Thomas H. Cartwright, Edward McKenna, Muhammad Wasif Saif, Steve Lee, Greg Yothers, Daniel G. Haller

The Lancet Oncology

Gastrointestinal OncologyMedicineIndividual Patient DataAdjuvant CapecitabinePost-relapse SurvivalColorectal CancerCancer TreatmentOncologyRadiation OncologyCancer Research